Govt Job for M.Pharm, M.Sc under Dept of Science and Technology

Jamia Hamdard was conceived as a seat of higher learning in Unani Medicine, Islamic Studies, Biosciences, Pharmacy, Nursing and other areas of knowledge by its founder as a means of fulfilling the objects of the wakf.

Over a period of last ten years, Jamia Hamdard has emerged as an outstanding institution of higher learning with distinct and focused academic programmes.

Graduate programme in Information Technology and Computer Applications and Post-graduate programmes in Information Technology, Computer Applications, Business Management, Physiotherapy and Occupational Therapy have been started in the last few years.

ADVERTISEMENT FOR JUNIOR RESEARCH FELLOW IN THE RESEARCH PROJECT SPONSORED BY SERB, DEPARTMENT OF SCIENCE & TECHNOLOGY, GOVT. OF INDIA

Tile of Project: “Cognitive remediation through Behavioral Reinforcement in Traumatic Brain Injury”

Essential qualifications :

M.Sc. Toxicology or M.Pharm. (Pharmacology) with first division
Qualified NET – JRF/LS examination of CSIR/UGC/ICMR for M.Sc. applicants or GATE for M.Pharm. applicants

Desirable : Experience in surgical models of rodents

Duration of appointment : Initially for a period of one year

Candidates fulfilling the eligibility criteria may submit the application along with recent CV and other relevant documents to the Principal Investigator, Prof. Suhel Parvez, Head, Department of Medical Elementology & Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062 only by email (sparvez@jamiahamdard.ac.in).

Last date of receipt of applications is 19th April 2021.

Only short-listed candidates will be called for an interview.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore